Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli +4 more
wiley +1 more source
Thyroid dysfunction in elderly first-episode drug-naïve major depressive disorder patients with comorbid dyslipidemia: prevalence, clinical profile and associated factors. [PDF]
Song X, Yi L, Wang S, Zhang X.
europepmc +1 more source
Does Current Thyroid Cancer Staging Accurately Reflect the Impact of Lymph Node Metastases on Survival in Younger Patients? [PDF]
Mohamed A. Adam +3 more
openalex +1 more source
The anatomical knowledge of Namibian school children
Abstract The public has limited knowledge of key organs and anatomical structures. The lack of anatomical knowledge and understanding can hinder time to access healthcare, quality of care, and treatment outcomes. The current study investigated the anatomical knowledge among Namibian children by comparing 8 school grades—4 to 12, which covers children ...
Adam M. Taylor +3 more
wiley +1 more source
Atypical Visually Guided Precision Grip Control in Middle‐Aged and Older Autistic Adults
ABSTRACT Sensorimotor impairments are well documented in autism spectrum disorder (ASD). However, little is known about how these difficulties present in middle‐aged and older autistic adults or how they relate to demographic factors and autistic traits.
Zheng Wang +9 more
wiley +1 more source
High-grade Thyroid Cancer Diagnosed After Radiofrequency Ablation Therapy With Multiple Benign Biopsies. [PDF]
Endo M +5 more
europepmc +1 more source
Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature [PDF]
Christopher Munoz‐Bendix +6 more
openalex +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source

